Anal Canal Cancer
📧 Sign up to get email alerts when something new happens for Anal Canal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers [NA]
Clinical trial results evaluating medico-economic aspects of IMRT techniques (Hi Art, RapidArc, VMAT) in prostate, cervix, and anal canal ca…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection [Phase 2]
Phase 2 clinical trial evaluating surgery for early-stage anal canal cancer or perianal cancer in HIV-infected patients; the study has compl…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma [EARLY_Phase 1]
Update on an early-phase trial evaluating concurrent chemoradiation with 5-fluorouracil and mitomycin-C for anal canal cancer; the study has…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life [Phase 2]
Phase 2 study assessing the efficacy, safety, and quality of life outcomes of combining simultaneous integrated boost radiotherapy (SIB-IMRT…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) [Phase 2]
A Phase 2 trial (VolATIL) evaluating UCPVax vaccine in combination with atezolizumab for HPV-positive cancers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients [Phase 2]
A Phase 2 trial evaluating PD-1 blockade with chemotherapy followed by concurrent immunoradiotherapy in locally advanced anal canal cancer a…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus [Phase 1, Phase 2]
Phase 1/2 trial evaluating radiochemotherapy with Panitumumab for localized anal canal cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer [Phase 2]
Phase 2 trial comparing cisplatin/fluorouracil versus carboplatin/paclitaxel in patients with inoperable locally recurrent or metastatic ana…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients [Phase 3]
Phase 3 trial evaluating chemoradiotherapy with or without PD-1 blockade for anal canal squamous carcinoma; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients [Phase 3]
Phase 3 trial updating efficacy of chemoradiotherapy with or without paclitaxel in squamous-cell anal carcinoma is ongoing or not yet determ…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates
This clinical trial update reports on a completed study comparing two dose rates of interstitial brachytherapy boost for anal canal cancer.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. [Phase 2]
A Phase 2 clinical trial completed in Brazil evaluated substituting capecitabine for 5-FU in chemoradiotherapy for squamous cell carcinoma o…